COVID‐19 and economy M Gupta, A Abdelmaksoud, M Jafferany, T Lotti, R Sadoughifar, M Goldust Dermatologic therapy 33 (4), 2020 | 246 | 2020 |
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain-A potential clue to the role of androgens in COVID-19 severity A Goren, S Vano-Galvan, CG Wambier, J McCoy, A Gomez-Zubiaur, ... J Cosmet Dermatol 19 (7), 1545-1547, 2020 | 215 | 2020 |
Herpes zoster: A Review of Clinical Manifestations and Management A Patil, M Goldust, U Wollina Viruses 14 (2), 192, 2022 | 186 | 2022 |
Treatment of scabies: Comparison of permethrin 5% versus ivermectin M Goldust, E Rezaee, S Hemayat The Journal of dermatology 39 (6), 545-547, 2012 | 111 | 2012 |
Machine learning and its application in skin cancer K Das, CJ Cockerell, A Patil, P Pietkiewicz, M Giulini, S Grabbe, ... International Journal of Environmental Research and Public Health 18 (24), 13409, 2021 | 98 | 2021 |
Acanthosis nigricans: a review A Das, D Datta, M Kassir, U Wollina, H Galadari, T Lotti, M Jafferany, ... Journal of cosmetic dermatology 19 (8), 1857-1865, 2020 | 90 | 2020 |
Pemphigus vulgaris and bullous pemphigoid: update on diagnosis and treatment V Di Lernia, DM Casanova, M Goldust, C Ricci Dermatology practical & conceptual 10 (3), 2020 | 88 | 2020 |
Treatment options for leishmaniasis S Pradhan, RA Schwartz, A Patil, S Grabbe, M Goldust Clinical and experimental dermatology 47 (3), 516-521, 2022 | 78 | 2022 |
Complications of botulinum toxin and fillers: a narrative review M Kassir, M Gupta, H Galadari, G Kroumpouzos, A Katsambas, T Lotti, ... Journal of cosmetic dermatology 19 (3), 570-573, 2020 | 68 | 2020 |
Emerging drugs for the treatment of vitiligo P Karagaiah, Y Valle, J Sigova, N Zerbinati, P Vojvodic, D Parsad, ... Expert opinion on emerging drugs 25 (1), 7-24, 2020 | 68 | 2020 |
Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies M Goldust, E Rezaee, R Raghifar Cutaneous and Ocular Toxicology 33 (4), 333-336, 2014 | 66 | 2014 |
Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. SB Nejad, HH Qadim, L Nazeman, R Fadaii, M Goldust Pakistan journal of biological sciences: PJBS 16 (12), 570-574, 2013 | 60 | 2013 |
Cyclosporine therapy during the COVID-19 pandemic L Rudnicka, P Glowacka, M Goldust, M Sikora, M Sar-Pomian, ... Journal of the American Academy of Dermatology 83 (2), e151-e152, 2020 | 58 | 2020 |
Psoriasis and respiratory comorbidities: the added value of fraction of exhaled nitric oxide as a new method to detect, evaluate, and monitor psoriatic systemic involvement and … P Santus, M Rizzi, D Radovanovic, A Airoldi, A Cristiano, R Conic, ... BioMed Research International 2018, 2018 | 58 | 2018 |
Scabies: a comprehensive review and current perspectives P Arora, L Rudnicka, M Sar‐Pomian, U Wollina, M Jafferany, T Lotti, ... Dermatologic therapy 33 (4), e13746, 2020 | 57 | 2020 |
Solidarity and transparency against the COVID‐19 pandemic G Arora, G Kroumpouzos, M Kassir, M Jafferany, T Lotti, R Sadoughifar, ... Dermatologic therapy 33 (4), 2020 | 56 | 2020 |
Priorities for global health community in COVID‐19 pandemic L Rudnicka, M Gupta, M Kassir, M Jafferany, T Lotti, R Sadoughifar, ... Dermatologic therapy 33 (4), 2020 | 54 | 2020 |
Will teledermatology be the silver lining during and after COVID‐19? A Sharma, V Jindal, P Singla, M Goldust, M Mhatre Dermatologic Therapy 33 (4), e13643, 2020 | 53 | 2020 |
5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety R Dhurat, A Sharma, L Rudnicka, G Kroumpouzos, M Kassir, H Galadari, ... Dermatologic therapy 33 (3), e13379, 2020 | 49 | 2020 |
Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum M Goldust, EL Hagstrom, D Rathod, AG Ortega-Loayza Expert Review of Clinical Pharmacology 13 (2), 157-161, 2020 | 49 | 2020 |